. 2020 Aug 14;28(2):185–197. doi: 10.4103/ipj.ipj_3_19

Table 8.

Comparison of dose of trihexyphenidyl (mg/day) across the three treatment groups

Trihexyphenidyl (mg/day)	Treatment group	Mean±SD	df	F	P
Dose of trihexyphenidyl at 1^st week	Lithium	2.66±1.51	2	24.62	0.000
	Carbamazepine	0.30±0.97
	Sodium valproate	0.47±1.32
Dose of trihexyphenidyl at 2^nd week	Lithium	2.86±1.25	2	1.19	0.311
	Carbamazepine	2.50±1.43
	Sodium valproate	2.23±1.56
Dose of trihexyphenidyl at 3^rd week	Lithium	2.86±1.13	2	0.30	0.738
	Carbamazepine	2.60±1.31
	Sodium valproate	2.82±1.23
Dose of trihexyphenidyl at 4^th week	Lithium	2.86±1.00	2	0.60	0.551
	Carbamazepine	2.50±1.43
	Sodium valproate	2.82±1.23
Dose of trihexyphenidyl at 5^th week	Lithium	2.46±1.00	2	0.52	0.597
	Carbamazepine	2.50±1.43
	Sodium valproate	2.82±1.23

df – Degree of freedom; P<0.05, F – ANOVA value. SD – Standard deviation